½ÃÀ庸°í¼­
»óǰÄÚµå
1744614

¼¼°èÀÇ ¿Ã·¹¾Æ³î»ê ½ÃÀå : ½ÃÀå ¿¹Ãø - À¯Çüº°, ¿ëµµº°, Áö¿ªº° ºÐ¼®(-2032³â)

Oleanolic Acid Market Forecasts to 2032 - Global Analysis By Type (30% Oleanolic Acid, 80% Oleanolic Acid, 90% Oleanolic Acid, 95% Oleanolic Acid, 98% Oleanolic Acid, and Other Types), Application and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¿Ã·¹¾Æ³î»ê ½ÃÀåÀº 2025³â¿¡ 3,183¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 7.6%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2032³â±îÁö´Â 5,316¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ¿Ã·¹¾Æ³î»êÀº ¿Ã¸®ºê, °úÀÏ, ¾àÃÊ µî ´Ù¾çÇÑ ½Ä¹°¿¡ ÇÔÀ¯µÈ õ¿¬ À¯·¡ Æ®¸®Å׸£Æä³ëÀ̵å È­ÇÕ¹°ÀÔ´Ï´Ù. ±× À¯ÀÍÇÑ Æ¯¼ºÀ¸·Î ¾Ë·ÁÁ® Ç×»êÈ­ ÀÛ¿ë, Ç׿°Áõ ÀÛ¿ë, °£ º¸È£ ÀÛ¿ëÀ» ³ªÅ¸³À´Ï´Ù. °£Àå¾Ö, ¾Ï, ´ç´¢º´, ¹Ì»ý¹° °¨¿°Áõ µîÀÇ Ä¡·á °¡´É¼ºÀÌ ³Î¸® Á¶»çµÇ°í ÀÖÀ¸¸ç, ¿Ã·¹¾Æ³î»êÀº ÀüÅëÀÇÇп¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ±× »ý¹°ÇÐÀû °æ·Î¸¦ Á¶ÀýÇÏ´Â ´É·ÂÀ¸·Î ÀǾàǰÀ̳ª Ä¡·á¿¡ ¿ëµµ°¡ ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

õ¿¬ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

¼ÒºñÀڴ ƯÈ÷ ÀǾàǰ, ¿µ¾ç º¸Á¶ ½Äǰ, È­Àåǰ¿¡ À־, °Ç°­ ÁöÇâÀÇ °íÁ¶¿Í Ŭ¸° ¶óº§ Á¦Ç°¿¡ ´ëÇÑ ¼±È£·ÎºÎÅÍ, ÇÕ¼º ¼ººÐ¿¡ ´ëÇÑ Ãµ¿¬ ¼ººÐÀ» ¿ä±¸ÇÏ´Â °æÇâÀÌ °­ÇØÁö°í ÀÖ½À´Ï´Ù. ¿Ã·¹¾Æ³î»êÀº ¿Ã¸®ºê ÀÙ µî ½Ä¹°¿¡ ÇÔÀ¯µÈ õ¿¬À¯·¡ Æ®¸®Å׸£Æä³ëÀ̵å È­ÇÕ¹°·Î Ç׿°Áõ ÀÛ¿ë, Ç×»êÈ­ ÀÛ¿ë, °£ º¸È£ ÀÛ¿ë µîÀÇ »ý¸®È°¼º Ư¼ºÀ» °®Ãß°í ÀÖ¾î ¿µ¾çº¸Á¶½ÄǰÀ̳ª ½ºÅ²Äɾî Á¦Ç°¿¡ ¹èÇÕÇϱ⿡ ÀûÇÕÇÕ´Ï´Ù. ÀÌ·¯ÇÑ È¿´ÉÀ» Áõ¸íÇÏ´Â °úÇÐÀû Á¶»ç´Â ¼ÒºñÀÚÀÇ ½Å·Ú¿Í Á¦Á¶»çÀÇ °ü½ÉÀ» ´õ¿í ³ôÀÌ°í ´Ù¾çÇÑ ¿ëµµ·Î ¿Ã·¹¾Æ³î»êÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

³ôÀº ÃßÃâ ¹× Á¤Á¦ ºñ¿ë

¿Ã·¹¾Æ³î»êÀº º¸Åë ¿Ã¸®ºê ÀÙ°ú Çãºê¿Í °°Àº ½Ä¹°¿¡¼­ ÃßÃâµÇ±â ¶§¹®¿¡ º¹ÀâÇÏ°í ¹ø°Å·Î¿î ÃßÃâ °øÁ¤ÀÌ ÇÊ¿äÇÕ´Ï´Ù. °í¼øµµ¸¦ ´Þ¼ºÇϱâ À§Çؼ­´Â Å©·Î¸¶Åä±×·¡Çdzª ¿ë¸ÅÃßÃâ°ú °°Àº °íµµÀÇ ±â¼úÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹¾Æ Á¦Á¶ºñ¿ëÀÌ Å©°Ô »ó½ÂÇÕ´Ï´Ù. °Ô´Ù°¡ õ¿¬ ÀÚ¿øÀ¸·ÎºÎÅÍÀÇ Ç°Áú°ú ¼öÈ®·®ÀÇ Àϰü¼ºÀ» À¯ÁöÇÏ´Â °ÍÀº °ï¶õÇϸç, ´ë±Ô¸ð »ó¾÷Àû ÀÌ¿ëÀ» À§ÇÑ È®À强ÀÇ ¹®Á¦·Î À̾îÁý´Ï´Ù. ÀÌ·¯ÇÑ ³ôÀº Á¶¾÷ ºñ¿ëÀº, Á¦Á¶¾÷ÀÚ, ƯÈ÷ Áß¼Ò±â¾÷¿¡ À־, ½ÃÀå¿¡ ´ëÇÑ Âü°¡ ¹× È®´ëÀÇ Á·¼â°¡ µË´Ï´Ù. ±× °á°ú, »ý»ê ºñ¿ëÀÇ ±ÞµîÀÌ Àû´çÇÑ °¡°ÝÀÇ ¹æÇذ¡ µÇ¾î, ¾÷°è Àüü·ÎÀÇ Æø³ÐÀº º¸±ÞÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù.

½ºÅ²Äɾî Á¦Ç°ÀÇ Ã³¹æ Áõ°¡

Á¶»ç¿¡ ÀÇÇϸé, ¿Ã·¹¾Æ³î»êÀº Äݶó°Õ »ý»êÀ» ÀÚ±ØÇØ, MMP-1°ú °°Àº Äݶó°Õ ºÐÇØ È¿¼Ò¸¦ ÀúÇØÇÏ´Â °ÍÀ¸·Î, ÁÖ¸§À» ÁÙÀ̰í, ÇǺÎÀÇ Åº·Â¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶Ç, ÇÇÁöÀÇ ºÐºñ¸¦ Á¶Á¤ÇÏ´Â ÀÛ¿ëÀÌ Àֱ⠶§¹®¿¡ Áö¼º ÇǺγª ¿©µå¸§ ÇǺο¡µµ È¿°úÀûÀÔ´Ï´Ù. ³·Àº ¼ö¿ë¼ºÀ» ±Øº¹Çϱâ À§ÇØ °íºÐÀÚ ¹Ì¼¿, ³ª³ë ¿¡¸Ö¼Ç µî Çõ½ÅÀûÀÎ ¹è´Þ ½Ã½ºÅÛÀÌ °³¹ßµÇ¾î ÇǺΠħÅõ¼º°ú ¾ÈÁ¤¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ¾ÈƼ¿¡ÀÌ¡ Å©¸², ¹Ì¿ë¾×, ·Î¼Ç¿¡ ³Î¸® »ç¿ëµÇ¸é¼­ õ¿¬ÀûÀ̰í È¿°úÀûÀÎ ½ºÅ²ÄÉ¾î ¼ººÐ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼ö¿ä Áõ°¡¿Í ÀÏÄ¡Çϰí ÀÖ½À´Ï´Ù.

ÇÕ¼º ´ëüǰ°úÀÇ Ä¡¿­ÇÑ °æÀï

ÇÕ¼º È­ÇÕ¹°Àº ´ëºÎºÐÀÇ °æ¿ì À¯»çÇÑ Ä¡·á È¿°ú¿Í ¹Ì¿ë È¿°ú¸¦ º¸´Ù Àú·ÅÇÑ ºñ¿ëÀ¸·Î º¸´Ù ¾ÈÁ¤ÀûÀΠǰÁú°ú °ø±ÞÀ¸·Î Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ´ëü È­ÇÕ¹°Àº ±Ô¸ð¿¡ µû¸¥ Á¦Á¶°¡ ¿ëÀÌÇϱ⠶§¹®¿¡ ³ó»ê¹° °ø±Þ¿øÀ̳ª º¹ÀâÇÑ ÃßÃâ °úÁ¤¿¡ ´ëÇÑ ÀÇÁ¸À» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ È­ÇÐ ÇÕ¼ºÀÇ Áøº¸·Î È¿´ÉÀ» ³ôÀÎ µ¶ÀÚÀûÀÎ È­ÇÕ¹°ÀÇ °³¹ßÀÌ °¡´ÉÇØÁ® ƯÁ¤ ¿ëµµ¿¡¼­´Â ¿Ã·¹¾Æ³î»ê°ú °°Àº õ¿¬ ¼ººÐÀ» ´É°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±× °á°ú Á¦Á¶»çµéÀº ºñ¿ë ´ëºñ È¿°ú°¡ ³ôÀº ÇÕ¼ºÇ°À» ¼±È£ÇÏ°Ô µÇ°í, õ¿¬ À¯·¡ ¿Ã·¹¾Æ³î»ê Á¦Ç°ÀÇ ½ÃÀå ħÅõ¿Í »ó¾÷Àû ½ÇÇö¼ºÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ ´ëÀ¯ÇàÀº ¿Ã·¹¾Æ³î»ê ½ÃÀå¿¡ ´Ù¾çÇÑ ¿µÇâÀ» ÁÖ¾ú½À´Ï´Ù. ´çÃÊ °ø±Þ¸ÁÀÇ È¥¶õ°ú Á¦Á¶ Ȱµ¿ÀÇ ÀúÇÏ¿¡ ÀÇÇØ »ý»ê°ú À¯ÅëÀÌ ¸ØÃè½À´Ï´Ù. ±×·¯³ª ÆÒµ¥¹Í µ¿¾È °Ç°­°ú ¸é¿ª¿¡ ´ëÇÑ ¼ÒºñÀÚµéÀÇ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿Ã·¹¾Æ³î»êÀ» Æ÷ÇÔÇÑ Ä¡·á È¿°ú°¡ Àִ õ¿¬ È­ÇÕ¹°¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁ³½À´Ï´Ù. ¼ÒºñÀÚ°¡ ÀÚ¿¬ ¿ä¹ýÀ» ¿ä±¸ÇÏ´Â °¡¿îµ¥, º¸ÃæÁ¦³ª ½ºÅ² Äɾî Á¦Ç°¿¡ ´ëÇÑ ÀÌ¿ëÀÌ È®»êµÇ¾ú½À´Ï´Ù. ÀüüÀûÀ¸·Î ´Ü±âÀûÀΠȥ¶õÀº ¹ß»ýÇßÁö¸¸, °Ç°­ ÀǽÄÀÇ °íÁ¶·Î ¿Ã·¹¾Æ³î»êÀÇ Àå±âÀûÀÎ Àü¸ÁÀº °³¼±µÇ¾ú½À´Ï´Ù.

95% ¿Ã·¹¾Æ³î»ê ºÎ¹®ÀÌ ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë°¡ µÉ Àü¸Á

95% ¿Ã·¹¾Æ³î»ê ºÎ¹®Àº ±× °í¼øµµ¿¡ ÀÇÇØ ÀǾàǰ, ¿µ¾çº¸Á¶½Äǰ, È­Àåǰ ¿ëµµ¿¡¼­ÀÇ À¯È¿¼ºÀÌ ³ô¾ÆÁö±â ¶§¹®¿¡ ¿¹Ãø ±â°£ Áß ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °í¼øµµÀÇ ¿Ã·¹¾Æ³î»êÀº ÀϰüµÈ Ä¡·á È¿°ú¸¦ º¸ÀåÇϱ⠶§¹®¿¡ °í±Þ ½ºÅ²Äɾî Á¦Ç°, °£ ¿µ¾çÁ¦, Ç׿°ÁõÁ¦ ó¹æ¿¡ ¸Å¿ì ÀûÇÕÇÕ´Ï´Ù. °Ô´Ù°¡ ±ÔÁ¦ ±âÁØÀÇ °íÁ¶¿Í °í±Þ½º·´°í È¿´ÉÀÌ ³ôÀº õ¿¬ ¼ººÐ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£°¡ ¼øµµ 95%ÀÇ ¿Ã·¹¾Æ³î»ê ½ÃÀå ¼ö¿ä¸¦ ´õ¿í ²ø¾î¿Ã¸®°í ÀÖ½À´Ï´Ù.

È­Àåǰ ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀÌ ¿¹»óµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È È­Àåǰ ºÐ¾ß´Â ±× °­·ÂÇÑ ¾ÈƼ ¿¡ÀÌ¡, Ç× ¿°Áõ, Ç×»êÈ­ ÀÛ¿ëÀ¸·Î °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ÒºñÀÚµéÀº ½ºÅ²Äɾ õ¿¬ ¼ººÐÀ» ã´Â °æÇâÀÌ °­ÇØÁö°í ÀÖÀ¸¸ç, ¿Ã·¹¾Æ³î»êÀº ÁÖ¸§À» ÁÙÀ̰í ÇÇÁö¸¦ Á¶ÀýÇϸç ÇǺΠź·Â¼ºÀ» Çâ»ó½ÃÅ´À¸·Î½á ÀÌ Ãß¼¼¿¡ ºÎÇÕÇϰí ÀÖ½À´Ï´Ù. Å©¸², ¹Ì¿ë¾×, ·Î¼Ç¿¡ ¹èÇյǾî Á¦Ç°ÀÇ Â÷º°È­¸¦ ²ÒÇÒ ¼ö ÀÖ´Â ÇÑÆí, Ŭ¸° ¶óº§ÀÇ ¹Ì¿ë Á¦Ç°¿¡ÀÇ ¼ö¿äÀÇ °íÁ¶·Î ¼¼°èÀÇ È­Àåǰ ó¹æ¿¡ÀÇ Ã¤¿ëÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª :

¿¹Ãø ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀº Á¦¾à ¹× È­Àåǰ »ê¾÷ÀÌ °­Çϱ⠶§¹®¿¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Áß±¹, ÀϺ», Çѱ¹°ú °°Àº ³ª¶óµéÀº õ¿¬ ¼ººÐÀÇ ¿¬±¸¿Í »ý»ê¿¡¼­ ¾Õ¼­°í ÀÖ½À´Ï´Ù. ÇѾàÀ̳ª À¯±â³ó ½ºÅ²Äɾ ´ëÇÑ ¼ö¿äÀÇ °íÁ¶°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½Ä¹° À¯·¡ÀÇ Á¦Á¦¸¦ Áö¿øÇÏ´Â Á¤ºÎÀÇ ´ëó°¡, ä¿ëÀ» ÇÑÃþ ´õ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµÇÁö¸¸, À̰ÍÀº õ¿¬ °Ç°­ Á¦Ç° ¼ö¿ä Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. Á¦¾à ¾÷°è´Â ¿Ã·¹¾Æ³î»êÀÇ Ä¡·á È¿°ú¿¡ °üÇÑ Á¶»ç¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. È­Àåǰ ºÐ¾ß¿¡¼­´Â À¯±â³ó ½ºÅ²Äɾî Á¦Á¦°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ½Ä¹° À¯·¡ È­ÇÕ¹°¿¡ ´ëÇÑ ±ÔÁ¦ Áö¿øÀÌ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¹«·á ÁÖ¹®À» ¹Þ¾Æ¼­ ¸¸µå´Â ¼­ºñ½º :

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ãß°è, ¿¹Ãø ¹× CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç Á¤º¸¿ø
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¿Ã·¹¾Æ³î»ê ½ÃÀå : À¯Çüº°

  • ¿Ã·¹¾Æ³î»ê 30%
  • ¿Ã·¹¾Æ³î»ê 80%
  • ¿Ã·¹¾Æ³î»ê 90%
  • ¿Ã·¹¾Æ³î»ê 95%
  • ¿Ã·¹¾Æ³î»ê 98%
  • ±âŸ À¯Çü

Á¦6Àå ¼¼°èÀÇ ¿Ã·¹¾Æ³î»ê ½ÃÀå : ¿ëµµº°

  • ÀǾàǰ
  • È­Àåǰ
  • °Ç°­ ½Äǰ
  • ±âŸ ¿ëµµ

Á¦7Àå ¼¼°èÀÇ ¿Ã·¹¾Æ³î»ê ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷ ¹× ÇÕÀÛÅõÀÚ
  • Àμö ¹× ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Shaanxi Jiahe Phytochem Co., Ltd.
  • Focusherb
  • Sichuan Yuxin Pharmaceutical Co., Ltd.
  • Sabinsa
  • Sichuan Benepure Pharmaceutical
  • Sichuan Xieli Pharmaceutical Co., Ltd.
  • ZD Biological
  • New Natural Biotechnology Co.,Ltd.
  • Xian ZB Biotech Co.,Ltd.
  • Luyuan Bio-Tech
  • Sami Labs
  • Chemicea Pharma
  • Tokyo Chemical Industry(India) Pvt. Ltd.
  • MP Biomedicals
  • Sigma-Aldrich International GmbH
AJY 25.06.20

According to Stratistics MRC, the Global Oleanolic Acid Market is accounted for $31.83 million in 2025 and is expected to reach $53.16 million by 2032 growing at a CAGR of 7.6% during the forecast period. Oleanolic acid is a naturally occurring triterpenoid compound found in various plants, including olives, fruits, and medicinal herbs. Known for its beneficial properties, it exhibits antioxidant, anti-inflammatory, and hepatoprotective effects. Widely researched for its potential in treating liver disorders, cancer, diabetes, and microbial infections, oleanolic acid plays a vital role in traditional medicine. Its ability to modulate biological pathways makes it a promising candidate for pharmaceutical and therapeutic applications.

Market Dynamics:

Driver:

Rising demand for natural products

Consumers are increasingly seeking natural alternatives to synthetic ingredients, particularly in pharmaceuticals, nutraceuticals, and cosmetics, due to heightened health consciousness and a preference for clean-label products. Oleanolic acid, a naturally occurring triterpenoid compound found in plants like olive leaves, offers bioactive properties such as anti-inflammatory, antioxidant, and hepatoprotective effects, making it appealing for inclusion in dietary supplements and skincare formulations. Scientific research validating these benefits further boosts consumer confidence and manufacturer interest, accelerating the adoption of oleanolic acid across various applications.

Restraint:

High extraction and purification costs

The compound is typically derived from plant sources such as olive leaves and other herbs, which requires complex and labor-intensive extraction processes. Advanced techniques like chromatography and solvent extraction are often necessary to achieve high purity, increasing production costs substantially. Moreover, maintaining consistency in quality and yield from natural sources is challenging, leading to scalability issues for large-scale commercial use. These high operational costs can deter manufacturers, particularly small- to mid-sized enterprises, from entering or expanding in the market. As a result, the elevated production expenses hinder affordability and limit wider adoption across industries.

Opportunity:

Increasing skin care product formulations

Research indicates that oleanolic acid can stimulate collagen production and inhibit collagen-degrading enzymes like MMP-1, thereby reducing wrinkles and enhancing skin elasticity. Its ability to regulate sebum production also makes it beneficial for oily and acne-prone skin. To overcome its poor water solubility, innovative delivery systems such as polymeric micelles and nanoemulsions have been developed, improving skin penetration and stability. These advancements have led to its widespread use in anti-aging creams, serums, and lotions, aligning with the growing consumer demand for natural and effective skincare ingredients.

Threat:

Intense competition from synthetic alternatives

Synthetic compounds often offer similar therapeutic and cosmetic benefits at a lower cost and with greater consistency in quality and supply. These alternatives are easier to manufacture at scale, reducing dependency on agricultural sources and complex extraction processes. Additionally, advancements in chemical synthesis allow for the development of tailored compounds with enhanced efficacy, which can outperform natural ingredients like oleanolic acid in specific applications. As a result, manufacturers may prefer cost-effective synthetics, limiting the market penetration and commercial viability of naturally derived oleanolic acid products.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the oleanolic acid market. Initially, supply chain disruptions and reduced manufacturing activities slowed production and distribution. However, the rising consumer focus on health and immunity during the pandemic increased demand for natural compounds with therapeutic benefits, including oleanolic acid. Its use in supplements and skincare products gained traction as consumers sought natural remedies. Overall, while short-term disruptions occurred, the long-term outlook for oleanolic acid improved due to heightened health awareness.

The 95% oleanolic acid segment is expected to be the largest during the forecast period

The 95% oleanolic acid segment is expected to account for the largest market share during the forecast period, due to its high purity, which enhances its effectiveness in pharmaceutical, nutraceutical, and cosmetic applications. High-purity oleanolic acid ensures consistent therapeutic outcomes, making it ideal for formulating advanced skincare products, liver supplements, and anti-inflammatory medications. Additionally, increasing regulatory standards and consumer preference for premium, high-efficacy natural ingredients further boost the market demand for 95% purity oleanolic acid.

The cosmetics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cosmetics segment is predicted to witness the highest growth rate, due to its powerful anti-aging, anti-inflammatory, and antioxidant properties. Consumers are increasingly seeking natural ingredients in skincare, and oleanolic acid fits this trend by helping reduce wrinkles, control sebum, and improve skin elasticity. Its inclusion in creams, serums, and lotions supports product differentiation, while growing demand for clean-label beauty products accelerates its adoption across global cosmetic formulations.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its strong pharmaceutical and cosmetics industries. Countries like China, Japan, and South Korea are leading in natural ingredient research and production. The rising demand for herbal medicine and organic skincare is driving market growth. Government initiatives supporting plant-based formulations are further boosting adoption.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to increasing demand for natural health products. The pharmaceutical industry is investing in research on oleanolic acid's therapeutic benefits. The cosmetics sector is witnessing a surge in organic skincare formulations. Regulatory support for plant-based compounds is encouraging market expansion.

Key players in the market

Some of the key players profiled in the Oleanolic Acid Market include Shaanxi Jiahe Phytochem Co., Ltd., Focusherb, Sichuan Yuxin Pharmaceutical Co., Ltd., Sabinsa, Sichuan Benepure Pharmaceutical, Sichuan Xieli Pharmaceutical Co., Ltd., ZD Biological, New Natural Biotechnology Co.,Ltd., Xian ZB Biotech Co.,Ltd., Luyuan Bio-Tech, Sami Labs, Chemicea Pharma, Tokyo Chemical Industry (India) Pvt. Ltd., MP Biomedicals, and Sigma-Aldrich International GmbH.

Key Developments:

In January 2025, Merck and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom Opentrons Flex(R) workstation. Scientists and engineers will collaborate to develop and verify platform workflows utilizing Merck's broad offering of automation-enabled assays.

In May 2018, MP Biomedicals, LLC announced the installation of dedicated cleanrooms for animal origin (AO) and non-animal origin (NAO) products in their Ohio, USA facility. The addition of the ISO Class 6 clean rooms continues an ongoing initiative to meet the stringent quality control and regulatory compliance standards vital for biopharmaceutical and bioprocessing applications.

Types Covered:

  • 30% Oleanolic Acid
  • 80% Oleanolic Acid
  • 90% Oleanolic Acid
  • 95% Oleanolic Acid
  • 98% Oleanolic Acid
  • Other Types

Applications Covered:

  • Pharmaceuticals
  • Cosmetics
  • Health Foods
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Oleanolic Acid Market, By Type

  • 5.1 Introduction
  • 5.2 30% Oleanolic Acid
  • 5.3 80% Oleanolic Acid
  • 5.4 90% Oleanolic Acid
  • 5.5 95% Oleanolic Acid
  • 5.6 98% Oleanolic Acid
  • 5.7 Other Types

6 Global Oleanolic Acid Market, By Application

  • 6.1 Introduction
  • 6.2 Pharmaceuticals
  • 6.3 Cosmetics
  • 6.4 Health Foods
  • 6.5 Other Applications

7 Global Oleanolic Acid Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Shaanxi Jiahe Phytochem Co., Ltd.
  • 9.2 Focusherb
  • 9.3 Sichuan Yuxin Pharmaceutical Co., Ltd.
  • 9.4 Sabinsa
  • 9.5 Sichuan Benepure Pharmaceutical
  • 9.6 Sichuan Xieli Pharmaceutical Co., Ltd.
  • 9.7 ZD Biological
  • 9.8 New Natural Biotechnology Co.,Ltd.
  • 9.9 Xian ZB Biotech Co.,Ltd.
  • 9.10 Luyuan Bio-Tech
  • 9.11 Sami Labs
  • 9.12 Chemicea Pharma
  • 9.13 Tokyo Chemical Industry (India) Pvt. Ltd.
  • 9.14 MP Biomedicals
  • 9.15 Sigma-Aldrich International GmbH
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦